Oncology Corporate Profile
| 1.8950 | |
| -0.0350 |
MannKind Corporation focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer.
Website: http://www.mannkindcorp.com/
| Brand / Product | Class | Area of Study | Phase | Partnership |
|---|---|---|---|---|
| MKC1106 | immunotherapy | 1st line metastatic Melanoma | II | |
| MKC204 | IRE-1 Inhibitor | Multiple Myeloma | Preclinical |
Follow @OBRTweets